Lebrikizumab Eased Itch and Pain in Hand and Foot Eczema: ADtouch
New ADtouch findings reported by HCPLive show lebrikizumab eased itch and pain in hand and foot eczema — the sites patients feel most in daily function.
Topic
Topic
New ADtouch findings reported by HCPLive show lebrikizumab eased itch and pain in hand and foot eczema — the sites patients feel most in daily function.
Lilly's Phase 3b ADtouch trial shows 53% of hand-and-foot atopic dermatitis patients on EBGLYSS reached clear or almost clear ski…